Biophysical targeting of adenovirus vectors for gene therapy

Current Opinion in Molecular Therapeutics

Volumn 2, Issue 5, 2000, Pages 524-531

  Silman, N J ^a   Fooks, A R ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Adenovirus; Fiber protein; Gene delivery; Targeting; Viral vector

Indexed keywords

BISPECIFIC ANTIBODY; LIGAND; RECOMBINANT DNA; VIRUS PROTEIN; VIRUS RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; BINDING AFFINITY; COXSACKIE VIRUS; GENE INSERTION; GENE TARGETING; GENE THERAPY; HOST CELL; NONHUMAN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECOMBINANT DNA TECHNOLOGY; REVIEW; VIRUS CAPSID; VIRUS CELL INTERACTION;

ADENOVIRIDAE; ANIMALS; BIOPHYSICS; CAPSID; CAPSID PROTEINS; GENE THERAPY; GENETIC VECTORS; HUMANS; POLYMERS; RECEPTORS, VIRUS;

EID: 0033751577     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5
2. Viral vector targeting
3. Targeting adenovirus
4. High adenoviral loads stimulate NF κB-dependent gene expression in human vascular smooth muscle cells
5. Next-generation edanoviral vectors: New and improved
6. Construction of adenovirus vectors through Cre-lox recombination
7. Expanded-capacity adenoviral vectors - The helper-dependent vectors
8. A new adenoviral vector: Replacement of all viral coding sequences with 28kb of DNA independently expressing both full-length dystrophin and β-galactosidase
9. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis
10. Fine structure of adenovirus type 5.1. Virus capsid
11. Structure and assembly of adenoviruses
12. Molecular composition of the adenovirus type 2 virion
13. Adenoviridae: The viruses and their replication
14. Strategies to adapt adenoviral vectors for gene therapy applications: Targeting and integration
15. Isolation of a common receptor for Coksackie B viruses and adenoviruses 2 and 5
16. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coksackieviruses
17. 5 promote adenovirus internalization but not virus attachment
18. Adenovirus type 5 knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells
19. The human HLA-A *0201 aliele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber
20. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain
21. Expression of the adenovirus receptor and its interaction with the fiber knob
22. Adenoviridae and their replication
23. Fiberless recombinant adenoviruses: Virus maturation and infectivity in the absence of fiber
24. A helper-independent adenovirus vector with E1, E3 and fiber deleted: Structure and infectivity of fiberless particles
25. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies
26. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs
27. RGD inclusion in the hexon monomer provides adenovirus type-5 based vectors with a fiber knob-independent pathway for infection
28. A system for the propagation of adenoviral vectors with genetically modified receptor specificities
29. Targeted gene delivery by tropism-modified adenoviral vectors
30. Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base
31. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses
32. Efficient transfer of regulated genes in adipocytes and hepatoma cells by the combination of liposomes and replication-defective adenovirus
33. Adenovirus enhancement of polyethylenimine-mediated transfer of regulated genes in differentiated cells
34. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery
35. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo
36. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo
37. Modification of an adenoviral vector with biologically selected peptides: A novel strategy for gene delivery to cells of choice
38. Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens
39. Targeted delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor
40. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: Evidence for reduced toxicity and enhanced antitumor activity in mice
41. Use of a novel cross-linking method to modify adenovirus tropism
42. Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer
43. Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM
44. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector
45. The 'adenobody' approach to viral targeting: Specific and enhanced adenoviral gene delivery
46. Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin
47. Targeted adenovirus-mediated gene delivery to T-cells via CD3
48. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector
49. Characterization of the binding and internalization of tetanus toxin in a neuroblastoma hybrid cell line
50. Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7Å resolution
51. Structure of the receptor binding domain of adenovirus type 5 fiber protein
52. Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR
53. Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein
54. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae
55. Adenovirus type 5 and 7 capsid chimera: Fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes
56. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism
57. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein
58. Efficient gene transfer into human CD34+ cells by a retargeted adenovirus vector
59. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
60. Polylysine modification of adenoviral fiber protein enhances muscle cell transduction
61. Efficient gene delivery to the inflamed colon by local administration of recombinant adenovirus with normal or modified fiber structure
62. Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein
63. Transduction of bone marrow cells by the AdZ.F (pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells
64. Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma
65. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models
66. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob
67. An adenovirus vector with genetically-modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
68. Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector
69. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
70. Biotechnology industry responds to gene therapy death